Andrea Schaffer

NHMRC Early Career Research Fellow
Senior Lecturer

Dr Andrea Schaffer is a Senior Research Fellow in the Medicines Policy Research Unit at the Centre for Big Data Research in Health and holds an NHMRC Early Career  Fellowship. She is a pharmacoepidemiologist and biostatistician with 12 years’ experience conducting population health research using routinely collected Australian health data on a variety of topics. Her current research involves using state of the art statistical methodologies to explore the impact of pharmaceutical policy on medicine utilisation, prescribing practices, and health outcomes, with a particular interest in opioids and psychotropic medicines. She is an expert in interrupted time series analysis. Some of her current and past projects include: quantifying the impact of negative media on statin use and discontinuation; investigating the impact of increased restrictions on alprazolam on prescribing patterns and poisonings; examining trajectories of antipsychotic use before and during pregnancy; identifying predictors of adherence to cardiovascular medicines; and exploring changing patterns of opioid utilisation in Australia.

Journal articles
add
De Oliveira Costa J; Schaffer AL; Medland NA; Litchfield M; Narayan SW; Guy R; McManus H; Pearson SA, 2020, 'Adherence to Antiretroviral Regimens in Australia: A Nationwide Cohort Study', AIDS Patient Care and STDs, vol. 34, pp. 81 - 91, http://dx.doi.org/10.1089/apc.2019.0278
2020
Hsu B; Falster MO; Schaffer AL; Pearson S; Jorm L; Brieger DB, 2020, 'Antiplatelet therapy within 30 days of percutaneous coronary intervention with stent implantation', Medical Journal of Australia, http://dx.doi.org/10.5694/mja2.50507
2020
Chiu T; Brett J; Pearson S; Schaffer A, 2020, 'Patterns of pregabalin initiation and discontinuation after its subsidy in Australia', British Journal of Clinical Pharmacology, http://dx.doi.org/10.1111/bcp.14276
2020
Cairns R; Schaffer AL; Brown JA; Pearson SA; Buckley NA, 2020, 'Codeine use and harms in Australia: evaluating the effects of re-scheduling', Addiction, vol. 115, pp. 451 - 459, http://dx.doi.org/10.1111/add.14798
2020
Schaffer AL; Pearson S-A; Perez-Concha O; Dobbins T; Ward RL; van Leeuwen MT; Rhee JJ; Laaksonen MA; Craigen G; Vajdic CM, 2020, 'Diagnostic and health service pathways to diagnosis of cancer-registry notified cancer of unknown primary site (CUP).', PLoS One, vol. 15, pp. e0230373, http://dx.doi.org/10.1371/journal.pone.0230373
2020
Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson S-A, 2020, 'Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine.', Med J Aust, http://dx.doi.org/10.5694/mja2.50552
2020
Schaffer AL; Karanges EA; Buckley NA; Wilson A; Degenhardt L; Larance B; Pearson SA, 2019, 'Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based study', Pharmacoepidemiology and Drug Safety, vol. 28, pp. 97 - 105, http://dx.doi.org/10.1002/pds.4683
2019
Han D; Narayan SW; Zoega H; Litchfield M; Buckley NA; Pearson SA; Schaffer AL, 2019, 'Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debate', Pharmacoepidemiology and Drug Safety, vol. 28, pp. 521 - 527, http://dx.doi.org/10.1002/pds.4755
2019
Vajdic CM; Perez-Concha O; Dobbins T; Ward RL; Schaffer AL; van Leeuwen MT; Rhee JJ; Laaksonen MA; Craigen G; Pearson SA, 2019, 'Demographic, social and lifestyle risk factors for cancer registry-notified cancer of unknown primary site (CUP)', Cancer Epidemiology, vol. 60, pp. 156 - 161, http://dx.doi.org/10.1016/j.canep.2019.04.004
2019
Tang M; Schaffer A; Kiely BE; Daniels B; Simes RJ; Lee CK; Pearson SA, 2019, 'Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016)', British Journal of Cancer, vol. 121, pp. 904 - 911, http://dx.doi.org/10.1038/s41416-019-0612-5
2019
Vajdic CM; Perez-Concha O; Rhee JJ; Dobbins T; Ward RL; Schaffer AL; van Leeuwen MT; Laaksonen MA; Craigen G; Pearson SA, 2019, 'Health-related predictors of cancer registry-notified cancer of unknown primary site (CUP)', Cancer Epidemiology, vol. 61, pp. 1 - 7, http://dx.doi.org/10.1016/j.canep.2019.05.001
2019
Bruno C; Daniels B; Pearson SA; Buckley NA; Schaffer A; Zoega H, 2019, 'Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia', BMJ Quality and Safety, http://dx.doi.org/10.1136/bmjqs-2019-009897
2019
Tang M; Schaffer A; Pearson SA, 2019, 'Embracing the full spectrum of real-world data for cancer medicines research in Australia', Asia-Pacific Journal of Clinical Oncology, vol. 15, pp. 186 - 187, http://dx.doi.org/10.1111/ajco.13121
2019
Cairns R; Schaffer AL; Ryan N; Pearson SA; Buckley NA, 2019, 'Monitoring emerging prescription-drug related harms: a comment on Cairns et al. (2018)—in reply', Addiction, vol. 114, pp. 572 - 573, http://dx.doi.org/10.1111/add.14531
2019
Schaffer AL; Zoega H; Tran DT; Buckley NA; Pearson S; Havard A, 2019, 'Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristics', Australian & New Zealand Journal of Psychiatry, pp. 000486741984776 - 000486741984776, http://dx.doi.org/10.1177/0004867419847764
2019
Schaffer AL; Buckley NA; Cairns R; Pearson S, 2019, 'Comparison of Prescribing Patterns Before and After Implementation of a National Policy to Reduce Inappropriate Alprazolam Prescribing in Australia', JAMA network open, vol. 2, pp. e1911590, http://dx.doi.org/10.1001/jamanetworkopen.2019.11590
2019
Schaffer AL; Falster MO; Brieger D; Jorm LR; Wilson A; Hay M; Leeb K; Pearson S; Nasis A, 2019, 'Evidence-Practice Gaps in Postdischarge Initiation With Oral Anticoagulants in Patients With Atrial Fibrillation', Journal of the American Heart Association, vol. 8, pp. e014287, http://dx.doi.org/10.1161/JAHA.119.014287
2019
Morgan A; Joshy G; Schaffer A; Laba T-L; Litchfield M; Pearson S; Banks E, 2018, 'Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants', PLoS ONE, vol. 13, pp. e0208824, http://dx.doi.org/10.1371/journal.pone.0208824
2018
Brett J; Schaffer A; Dobbins T; Buckley NA; Pearson SA, 2018, 'The impact of permissive and restrictive pharmaceutical policies on quetiapine dispensing: Evaluating a policy pendulum using interrupted time series analysis', Pharmacoepidemiology and Drug Safety, vol. 27, pp. 439 - 446, http://dx.doi.org/10.1002/pds.4408
2018
Cairns R; Schaffer A; Ryan N; Pearson S; Buckley NA, 2018, 'Rising pregabalin use and misuse in Australia: trends in utilisation and intentional poisonings', Addiction, http://dx.doi.org/10.1111/add.14412
2018
Schaffer A; Buckley NA; Degenhardt L; Larance B; Cairns R; Dobbins T; Pearson SA, 2018, 'Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in Australia', Canadian Medical Association Journal, vol. 190, pp. E355 - E362, http://dx.doi.org/10.1503/cmaj.170666
2018
Joshi V; Adelstein BA; Schaffer A; Srasuebkul P; Dobbins T; Pearson SA, 2017, 'Validating a proxy for disease progression in metastatic cancer patients using prescribing and dispensing data', Asia-Pacific Journal of Clinical Oncology, vol. 13, pp. e246 - e252, http://dx.doi.org/10.1111/ajco.12602
2017
Schaffer AL; Buckley NA; Pearson SA, 2017, 'Who benefits from fixed-dose combinations? Two-year statin adherence trajectories in initiators of combined amlodipine/atorvastatin therapy', Pharmacoepidemiology and Drug Safety, vol. 26, pp. 1465 - 1473, http://dx.doi.org/10.1002/pds.4342
2017
Schaffer AL; Pearson SA; Buckley NA, 2016, 'How does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006–2014)', British Journal of Clinical Pharmacology, pp. 1134 - 1145, http://dx.doi.org/10.1111/bcp.13043
2016
Schaffer AL; Buckley NA; Cairns R; Pearson SA, 2016, 'Interrupted time series analysis of the effect of rescheduling alprazolam in Australia: Taking control of prescription drug use', JAMA Internal Medicine, vol. 176, pp. 1223 - 1225, http://dx.doi.org/10.1001/jamainternmed.2016.2992
2016
Gnjidic D; Pearson SA; Hilmer SN; Basilakis J; Schaffer AL; Blyth FM; Banks E, 2015, 'Manual versus automated coding of free-text self-reported medication data in the 45 and Up Study: A validation study', Public Health Research and Practice, vol. 25, http://dx.doi.org/10.17061/phrp2521518
2015
Schaffer AL; Buckley NA; Dobbins TA; Banks E; Pearson SA, 2015, 'The crux of the matter: Did the ABC’s catalyst program change Statin use in Australia?', Medical Journal of Australia, vol. 202, pp. 591 - 595, http://dx.doi.org/10.5694/mja15.00103
2015
Schaffer AL; Pearson SA; Dobbins TA; Er CC; Ward RL; Vajdic CM, 2015, 'Patterns of care and survival after a cancer of unknown primary (CUP) diagnosis: A population-based nested cohort study in Australian Government Department of Veterans' Affairs clients', Cancer Epidemiology, vol. 39, pp. 578 - 584, http://dx.doi.org/10.1016/j.canep.2015.02.007
2015
Mellish L; Karanges EA; Litchfield MJ; Schaffer AL; Blanch B; Daniels BJ; Segrave A; Pearson SA, 2015, 'The Australian Pharmaceutical Benefits Scheme data collection: A practical guide for researchers', BMC Research Notes, vol. 8, http://dx.doi.org/10.1186/s13104-015-1616-8
2015
Vajdic CM; Ward RL, 2015, 'Health service utilisation and investigations before diagnosis of cancer of unknown primary (CUP): A population-based nested case-control study in Australian Government Department of Veterans' Affairs client', Cancer Epidemiology, vol. 39, pp. 585 - 592, http://dx.doi.org/10.1016/j.canep.2015.02.006
2015
Pearson SA; Schaffer A, 2014, 'The use and impact of cancer medicines in routine clinical care: Methods and observations in a cohort of elderly Australians', BMJ Open, vol. 4, http://dx.doi.org/10.1136/bmjopen-2013-004099
2014
Ganda K; Schaffer A; Pearson S; Seibel MJ, 2014, 'Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: A randomised controlled trial of specialist vs. non-specialist management', Osteoporosis International, vol. 25, pp. 1345 - 1355, http://dx.doi.org/10.1007/s00198-013-2610-4
2014
Vajdic CM; Er CC; Schaffer A; Dobbins T; Wyld L; Meagher NS; Barrett J; Ward RL; Pearson SA, 2014, 'An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data', Cancer Epidemiology, vol. 38, pp. 460 - 464, http://dx.doi.org/10.1016/j.canep.2014.05.004
2014
Ganda K; Schaffer A; Seibel MJ, 2014, 'Predictors of re-fracture amongst patients managed within a secondary fracture prevention program: a 7-year prospective study', Osteoporosis International, vol. 26, pp. 543 - 551, http://dx.doi.org/10.1007/s00198-014-2880-5
2014
Schaffer A; Muscatello D; Cretikos M; Gilmour R; Tobin S; Ward J, 2012, 'The impact of influenza A(H1N1)pdm09 compared with seasonal influenza on intensive care admissions in New South Wales, Australia, 2007 to 2010: A time series analysis', BMC Public Health, vol. 12, http://dx.doi.org/10.1186/1471-2458-12-869
2012
Schaffer A; Muscatello D; Broome R; Corbett S; Smith W, 2012, 'Emergency department visits, ambulance calls, and mortality associated with an exceptional heat wave in Sydney, Australia, 2011: A time-series analysis', Environmental Health: A Global Access Science Source, vol. 11, http://dx.doi.org/10.1186/1476-069X-11-3
2012
Schaffer A; Brotherton J; Booy R, 2007, 'Do human papillomavirus vaccines have any role in newborns and the prevention of recurrent respiratory papillomatosis in children?', Journal of Paediatrics and Child Health, vol. 43, pp. 579 - 580, http://dx.doi.org/10.1111/j.1440-1754.2007.01205.x
2007
Schaffer A; Koushik A; Trottier H; Duarte-Franco E; Mansour N; Arseneau J; Provencher D; Gilbert L; Gotlieb W; Ferenczy A; Coutlée F; Pollak MN; Franco EL; Matlashewski G; Pollak M; Roger M; Piché S; Capek A; Juras A; Michon B; Florakas C; Landry D; Grandmont D; L'Heureux D; Dalton D; Queiros E; Dauth E; Leclerc F; Stanimir G; Hum HS; Czitrom JP; Dubuc-Lissoir J; Lord J; Mayrand MH; Dupuis MJ; Martin M; Roleau M; Plamondon M; Fournier P; Gauthier P; Drouin P; Fournier P; Jeanbart P; Shatz R; Piché R; Hunt R, 2007, 'Insulin-like growth factor-I and risk of high-grade cervical intraepithelial neoplasia', Cancer Epidemiology Biomarkers and Prevention, vol. 16, pp. 716 - 722, http://dx.doi.org/10.1158/1055-9965.EPI-06-0924
2007
Brotherton J; Wang H; Schaffer A; Quinn H; Menzies R; Hull B; Lawrence GL; Wood J; Wood N; Rosewell A; Newall AT; MacIntyre CR; Macartney K; Gidding HF; McIntyre P; Booy R, 2007, 'Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, vol. 31, pp. S1 - S152
2007
Conference Abstracts
add
Chiu T; Pearson S; Schaffer A, 2019, 'Pregabalin use outside subsidy restrictions in Australia', in Pharmacoepidemiology and Drug Safety, Wiley, Philadelphia, USA, presented at International Conference on Pharmacoepidemiology, Philadelphia, USA, 24 August 2019 - 28 August 2019, http://dx.doi.org/10.1002/pds.4864
2019
Schaffer A; Buckley N; Pearson S, 2019, 'Unintended Consequences of a National Policy Intervention to Curb Inappropriate Alprazolam Prescribing in Australia', in Pharmacoepidemiology and Drug Safety, Wiley, Philadelphia, USA, presented at International Conference on Pharmacoepidemiology and Drug Safety, Philadelphia, USA, 24 August 2019 - 28 August 2019, http://dx.doi.org/10.1002/pds.4864
2019
Schaffer A; Zoega H; Tran DT; Buckley N; Pearson S; Havard A, 2019, 'Trajectories of antipsychotic use before and during pregnancy and related maternal and birth characteristics', in Pharmacoepidemiology and Drug Safety, Wiley, Philadelphia, USA, presented at International Conference on Pharmacoepidemiology, Philadelphia, USA, 24 August 2019 - 28 August 2019, http://dx.doi.org/10.1002/pds.4864
2019
Schaffer AL; Buckley NA; Pearson S, 2019, 'Unintended Consequences of a National Policy Intervention to Curb Inappropriate Alprazolam Prescribing in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 34 - 35, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000481785600063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Reutfors J; Zoega H; Cesta C; Bateman BT; Cantarutti A; Cohen J; Corrao G; Einarsdottir K; Engeland A; Furu K; Havard A; Hernandez-Diaz S; Huybrechts KF; Karlsson P; Karlstad O; Li J; Schaffer A; Yu Y; Broms G, 2018, 'Antipsychotic drug use in pregnancy: A multinational database study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 27, pp. 235 - 235, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000441893802059&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Brieger D; Falster M; Schaffer A; Jorm L; Pearson S; Emerson L; Hay M; Nasis A; Wilson A, 2018, 'P2Y12 Inhibitor Therapy is Underutilised in Patients Hospitalised for Acute Myocardial Infarction: Results From a New Population-Level Data Linkage in Australia', in Heart, Lung and Circulation, Elsevier, Brisbane, Australia, presented at Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Brisbane, Australia
2018
Nasis A; Schaffer A; Falster M; Pearson S; Jorm L; Emerson L; Hay M; Brieger D; Wilson A, 2018, 'Use of Oral Anticoagulants After Hospital Discharge in Patients With Atrial Fibrillation: Insights From a New Population-Level Linkage in Australia', in Heart, Lung and Circulation, Elsevier, presented at Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand
2018
Schaffer AL; Buckley NA; Pearson S, 2017, 'Two-Year Statin Adherence Trajectories in Initiators of Combined Amlodipine-Atorvastatin Therapy: A Population-Based Study (2005–2015)', in Abstracts of the 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, WILEY, Montreal, Canada, Vol. 26, pp. 519 - 520, presented at International Conference on Pharmacoepidemiology, Montreal, Canada, 27 August 2017 - 30 August 2017, http://dx.doi.org/10.1002/pds.4275
2017
Schaffer AL; Buckley NA; Dobbins TA; Degenhardt L; Larance B; Pearson S-A, 2017, 'Opioid Switching After Introduction of a Tamper-Resistant Oxycodone Formulation in Australia: A Population-Based Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 26, pp. 212 - 212, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437103900349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2017
Reports
add
Schaffer A; Falster M; Pearson S; Jorm L; Wilson A; Nasis A; Brieger D, 2018, Delivering better cardiac outcomes: Primary, specialist and hospital care
2018
Zoega H; Schaffer A; Litchfield M; Pearson S, 2017, Post-market Review - Pulmonary Arterial Hypertension Medicines
2017
Conference Presentations
add
Schaffer AL; Buckley NA; Dobbins T; Degenhardt L; Larance B; Pearson SA, 2017, 'Opioid Switching After Introduction of a Tamper-Resistant Oxycodone Formulation in Australia: A Population-Based Study', presented at International Conference on Pharmacoepidemiology, Montreal, Canada, 27 August 2017 - 30 August 2017, http://dx.doi.org/10.1002/pds.4275
2017
Schaffer AL; pearson S; buckley N, 2016, 'Does Concordance with Fixed-Dose Combination (FDC) Treatment Guidelines Improve Persistence? An Australian Population Based Cohort Study.', Vol. 25 Suppl 3, pp. 3 - 679, presented at 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Dublin, Ireland, 25 August 2016 - 28 August 2016, http://dx.doi.org/10.1002/pds.4070
2016
Schaffer AL; Buckley NA; Dobbins T; Banks E; Pearson S-A, 2015, 'Time Series Analysis of the Impact of Adverse Media on Statin Dispensing and Discontinuation in Australia', Vol. 24, pp. 237 - 238, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000369980200411&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Vajdic CM; Schaffer A; Dobbins TA; Ward RL; Barrett J; Er CC; Pearson S-A, 2014, 'Health service utilisation and investigations before diagnosis of cancer of unknown primary (CUP): A population-based nested case-control study', Vol. 10, pp. 203 - 203, presented at 2014 World Cancer Congress, Melbourne, 03 December 2014 - 06 December 2014, http://dx.doi.org/10.1111/ajco.12332
2014
joshi V; adelstein BA; Schaffer AL; srasuebkul P; EoCC Investigators ; dobbins T; pearson S, 2013, 'A Proxy of Cancer Progression in Dispensing Claims: Validation and Performance', Vol. 22, presented at 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Montreal, Canada, 25 August 2016 - 28 August 2016, http://dx.doi.org/10.1002/pds.3512
2013
Schaffer AL; Pearson S-A; Dobbins T; Er C; Meagher NS; Barrett J; Ward RL; Vajdic CM, 2013, 'HEALTH SERVICE USE, TREATMENT PATTERNS, AND SURVIVAL FOR CANCER OF UNKNOWN PRIMARY: A DATA LINKAGE STUDY', Vol. 9, pp. 98 - 98, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2013
Schaffer AL; muscatello D; broome R; corbett S; smith W, 2011, 'Excess hospital admissions, ambulance calls and mortality during an exceptional heat wave in February 2011.', Vol. 18, presented at Australasian Epidemiological Association Annual Scientific Meeting, Perth, Australia, 01 September 2011
2011
Schaffer AL; levi C; moore H; rose N; gattelari M; worthington J, 2010, 'Use of linked hospital data to assess the impact of the introduction of tissue plasminogen activator (tPA) therapy on stroke outcomes in NSW.', Vol. 17, presented at Australasian Epidemiological Association 17th Annual Scientific Meeting, Sydney, Australia
2010
Conference Posters
add
Schaffer AL; Buckley NA; Cairns R; Pearson S-A, 2016, 'Up-Scheduling of Alprazolam to a "Controlled Drug": Interrupted Time Series Analysis of Its Impact on Benzodiazepine (BZD) Prescribing, Dispensing and Poisonings in Australia', Vol. 25, pp. 346 - 347, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385483502227&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2016

2019 - UNSW Medicine Early Career Academic Network (ECAN) Best Paper Award, Clinical, Health Services or Public Health category

2019 - Best Paper by an Early Career Researcher (Highly Commended) at the 11th Health Services and Research Association of Australian and New Zealand

2017 - Rising Star Award for best abstract presented by a junior investigator at the 10th Asian Conference on Pharmacoepidemiology

2016 - MJA, MDA National Prize for Excellence in Medical Research for best clinical paper published in the Medical Journal of Australia in 2015

2015 - Stanley A. Edlavitch award for best abstract submitted by a student to the 31st International Conference on Pharmacoepidemiology

 

 

NHMRC Ideas Grant (2021-2023) - "Disentangling the interrelationship between multimordibity, multimedicine use, and cardiovascular health"

NHMRC Project Grant (2019-2021) - "Health service and medicine utilisation before suicide: optimising suicide prevention using population-based linkage of routinely collected data" 

NHMRC Early Career Fellowship (2019-2022) - "Evaluating population-level medicine policy interventions: generating high-quality evidence about intended and unintended consequences"

NHMRC Post-graduate scholarship (2014-2017)